These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20332224)

  • 21. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
    Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
    Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer.
    Xi Z; Kaern J; Davidson B; Klokk TI; Risberg B; Tropé C; Saatcioglu F
    Gynecol Oncol; 2004 Jul; 94(1):80-5. PubMed ID: 15262123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of alphavbeta3 integrin expression is a novel molecular response to chemotherapy-induced cell damage in a heregulin-dependent manner.
    Vellon L; Menendez JA; Liu H; Lupu R
    Differentiation; 2007 Nov; 75(9):819-30. PubMed ID: 17999741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin alpha3beta1 engagement disrupts intercellular adhesion.
    Kawano K; Kantak SS; Murai M; Yao CC; Kramer RH
    Exp Cell Res; 2001 Jan; 262(2):180-96. PubMed ID: 11139342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer.
    Dorn J; Gkazepis A; Kotzsch M; Kremer M; Propping C; Mayer K; Mengele K; Diamandis EP; Kiechle M; Magdolen V; Schmitt M
    Biol Chem; 2014 Jan; 395(1):95-107. PubMed ID: 23999494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
    Santin AD; Cané S; Bellone S; Palmieri M; Siegel ER; Thomas M; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
    Cancer Res; 2005 May; 65(10):4334-42. PubMed ID: 15899825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor type 1 promotes fibrosarcoma cell migration by modifying cellular attachment to vitronectin via alpha(v)beta(5) integrin.
    Takahashi T; Suzuki K; Ihara H; Mogami H; Kazui T; Urano T
    Semin Thromb Hemost; 2005 Jun; 31(3):356-63. PubMed ID: 16052409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
    Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
    Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.
    Gong J; Wang D; Sun L; Zborowska E; Willson JK; Brattain MG
    Cell Growth Differ; 1997 Jan; 8(1):83-90. PubMed ID: 8993837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells.
    Azimian-Zavareh V; Dehghani-Ghobadi Z; Ebrahimi M; Mirzazadeh K; Nazarenko I; Hossein G
    Sci Rep; 2021 Mar; 11(1):5885. PubMed ID: 33723319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
    Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
    Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells.
    Lee DH; Chung K; Song JA; Kim TH; Kang H; Huh JH; Jung SG; Ko JJ; An HJ
    J Proteome Res; 2010 Nov; 9(11):5668-76. PubMed ID: 20858016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
    Hossein G; Halvaei S; Heidarian Y; Dehghani-Ghobadi Z; Hassani M; Hosseini H; Naderi N; Sheikh Hassani S
    Cancer Med; 2019 Aug; 8(9):4315-4329. PubMed ID: 31197964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.
    Silva LM; Kryza T; Stoll T; Hoogland C; Dong Y; Stephens CR; Hastie ML; Magdolen V; Kleifeld O; Gorman JJ; Clements JA
    Mol Cell Proteomics; 2019 May; 18(5):818-836. PubMed ID: 30705123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
    Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
    Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.